Komori
Mitsubishi Chemical Group (4188) · InitiativeAdvanced

Shareholder Returns and Capital Policy Through Share Buybacks

First written in FY2017. 3 of 6 entries say "Advanced", first in FY2018. Latest entry: FY2026.

6entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019AdvancedFY2025 – FY20262017: 120172018: 120182019: 120192020: 020202021: 020212022: 020222023: 020232024: 020242025: 220252026: 12026
Same theme, other companies
Shareholder Returns and Capital Policy through Treasury Share Acquisitions and CancellationsA theme 284 companies write about · 0 as a headwind · 286 as a tailwind

110 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 287 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Based on a resolution of the Board of Directors held on 13 May 2025, the Company acquired 64,821 thousand treasury shares (¥50,000 million) during the current interim consolidated accounting period. It also cancelled the 64,821 thousand treasury shares in October 2025.」

    The full-year report confirms the acquisition of 64.821 million treasury shares for ¥50 billion and the cancellation of all shares in October 2025, using funds obtained from the transfer of Mitsubishi Tanabe Pharma and other transactions.
  2. FY2026-H1AdvancedAnnual report

    「Based on a resolution of the Board of Directors held on 13 May 2025, the Company acquired 64,821 thousand treasury shares (¥50,000 million) during the current interim consolidated accounting period. It also cancelled the 64,821 thousand treasury shares in October 2025.」

    As a measure to enhance shareholder returns and improve capital efficiency using funds obtained from the transfer of Mitsubishi Tanabe Pharma and other transactions, the Company acquired 64.821 million treasury shares for ¥50 billion and cancelled all of the shares in October 2025.
  3. FY2025RaisedAnnual report

    「The Company resolved matters relating to the acquisition of treasury shares in order to use the funds obtained from this transaction to enhance shareholder returns and improve capital efficiency. It will also cancel all of the treasury shares acquired to enhance shareholder value over the medium to long term.」

    The Company resolved to acquire up to 100 million shares for a total of ¥50 billion and cancel all shares acquired, using funds obtained from the transaction involving Mitsubishi Tanabe Pharma. The scale and role of the acquisition in its capital policy have been expanded from previous treasury share acquisitions.
  4. FY2019RestatedAnnual report

    「During the fiscal year, 19,548,800 treasury shares were acquired for a total acquisition cost of ¥19,999,912,040.」

    The annual disclosure confirms the acquisition results for the treasury share acquisition in May 2018 disclosed in the previous filing.
  5. FY2018AdvancedAnnual report

    「At a meeting of the Board of Directors held on 10 May 2018, the Company resolved to acquire treasury shares pursuant to Article 459, paragraph 1 of the Companies Act and Article 40 of the Company’s Articles of Incorporation.」

    Based on the resolution adopted in May 2018, 19.549 million treasury shares were acquired for a total of ¥20 billion between 11 May and 1 June 2018.
  6. FY2017First statedAnnual report

    「Board of Directors resolution status (14 March 2017) (acquisition date: 15 March 2017): up to 50,000,000 shares and up to ¥30,000,000,000. Treasury shares acquired during the fiscal year: 33,370,400 shares, ¥29,999,989,600.」

    Based on the Board of Directors’ resolution of 14 March 2017, the Group acquired 33,370,400 treasury shares for approximately ¥30 billion on the following day.
Moved together

"Portfolio and Structural Reform of the Petrochemicals Business" moved the same way as this thread, in the same document, in 4 of its 6 moves.

444333★123456
  1. ★This thread
  2. 1Portfolio and Structural Reform of the Petrochemicals Business4×
  3. 2Building an Australia and Oceania platform through the acquisition of an industrial-gases business4×
  4. 3Strategic investments, including capital expenditure and M&A, in growth businesses4×
  5. 4Improving profitability through cost reductions and asset reduction3×
  6. 5Funding risks from interest-bearing debt, interest rates and credit-rating downgrades3×
  7. 6Innovation and joint research centred on R&D3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Mitsubishi Chemical Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.